Home
Science
ImmunoBody
®
Moditope
®
Glymab
®
Publications
Pipeline
News
Investors
Share Info
Financial Info
Documents & Presentations
Corporate Governance
Contact Us
Find a trial
Become an Investigator
Interim Results for the 6 months ended 31 October 2021
by
admin
|
Jan 26, 2022
|
Regulatory News
Next Entries »
Search
Search
Recent Posts
Form F-4/A (November 2026)
NASDAQ listing, iSCIB1+, and ModiFy updates
Scancell Provides Corporate and Clinical Update
Notice of Annual General Meeting November 2026
Result of General Meeting
Recent Comments
No comments to show.